EndothelinA Receptor Blockade Reduces Ischemia/Reperfusion Injury in Pig Pancreas Transplantation

Annals of Surgery

Volumn 238, Issue 2, 2003, Pages 264-274

  Witzigmann, Helmut ^a,b   Ludwig, Stefan ^a   Armann, Barbara ^a   Gäbel, Gabor ^a   Teupser, Daniel ^a   Kratzsch, Jürgen ^a   Pietsch, Uta Carolin ^a   Tannapfel, Andrea ^a   Geissler, Felix ^a   Hauss, Johann ^a   Uhlmann, Dirk ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Second Department of Surgery   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMBRISENTAN; AMYLASE; C REACTIVE PROTEIN; CYCLOSPORIN A; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; PREDNISOLONE; PREDNISOLONE HEMISUCCINATE; SODIUM CHLORIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL LIPASE; TRYPSINOGEN ACTIVATION PEPTIDE; VASOCONSTRICTOR AGENT; ENDOTHELIN; ENDOTHELIN RECEPTOR; OXYGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOWMETRY; BLOOD OXYGEN TENSION; CAPILLARY FLOW; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; ELECTRODE; ENZYME BLOOD LEVEL; EVALUATION; EXPERIMENTAL MODEL; FEMALE; GRAFT PRESERVATION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; ISCHEMIA; LASER DOPPLER FLOWMETRY; MICROCIRCULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS PERFUSION; PANCREAS TRANSPLANTATION; PANCREATITIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RECEPTOR BLOCKING; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; SWINE; TISSUE INJURY; TISSUE LEVEL; TISSUE SECTION; UPREGULATION; ACUTE HEMORRHAGIC PANCREATITIS; ANIMAL; BLOOD; BLOOD FLOW VELOCITY; COMPUTER GRAPHICS; DISEASE MODEL; DRUG ANTAGONISM; RANDOMIZATION;

AMYLASES; ANIMALS; BLOOD FLOW VELOCITY; C-REACTIVE PROTEIN; COMPUTER GRAPHICS; DISEASE MODELS, ANIMAL; ENDOTHELINS; LIPASE; OXYGEN; PANCREAS TRANSPLANTATION; PANCREATITIS, ACUTE NECROTIZING; RANDOM ALLOCATION; RECEPTOR, ENDOTHELIN A; RECEPTORS, ENDOTHELIN; REPERFUSION INJURY; SWINE;

EID: 0042413940     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200308000-00016     Document Type: Article

References (41)

1. Odorico JS, Sollinger HW. Technical and immunosuppressive advances in transplantation for insulin-dependent diabetes mellitus. World J Surg. 2002;26:194-211.
2. Grewal HP, Garland L, Novak K, et al. Risk factors for postimplantation pancreatitis and pancreatic thrombosis in pancreas transplant recipients. Transplantation. 1993;56:609-612.
3. Benz S, Schnabel R, Morgenroth K, et al. Ischemia/reperfusion injury of the pancreas: a new animal model. J Surg Res. 1998;75:109-115.
4. Benz S, Pfeffer F, Adam U, et al. Impairment of pancreatic microcirculation in the early reperfusion period during simultaneous pancreas-kidney transplantation. Transpl Int. 1998;11(suppl 1):S433-S435.
5. Mayer H, Schmidt J, Thies J, et al. Characterization and reduction of ischemia/reperfusion injury after experimental pancreas transplantation. J Gastrointest Surg. 1999;3:162-166.
6. Foitzik T, Faulhaber J, Hotz HG, et al. Endothelin receptor blockade improves fluid sequestration, pancreatic capillary blood flow, and survival in severe experimental pancreatitis. Ann Surg. 1998;228:670-675.
7. Wenner J, Rivera J, Fernandez-del Castillo C, et al. Differing roles of nitric oxide in the pathogenesis of acute edematous versus necrotizing pancreatitis. Surgery. 1997;121:23-30.
8. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
9. Davenport AP. International Union of Pharmacology. XXIX. Update on Endothelin Receptor Nomenclature. Pharmacol Rev. 2002;54:219-226.
10. Eibl G, Hotz HG, Faulhaber J, et al. Effect of endothelin and endothelin receptor blockade on capillary permeability in experimental pancreatitis. Gut. 2000;46:390-394.
11. Foitzik T, Eibl G, Buhr HJ. Therapy for microcirculatory disorders in severe acute pancreatitis: comparison of delayed therapy with ICAM-1 antibodies and a specific endothelin A receptor antagonist. J Gastrointest Surg 2000;4:240-247.
12. Foitzik T, Eibl G, Hotz HG, et al. Endothelin receptor blockade in severe acute pancreatitis leads to systemic enhancement of microcirculation, stabilization of capillary permeability, and improved survival rates. Surgery. 2000;128:399-407.
13. Foitzik T, Hotz HG, Eibl G, et al. Therapy for microcirculatory disorders in severe acute pancreatitis: effectiveness of platelet-activating factor receptor blockade vs. endothelin receptor blockade. J Gastrointest Surg. 1999;3:244-251.
14. Gudgeon AM, Heath DI, Hurley P, et al. Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis. Lancet. 1990;335:4-8.
15. Neoptolemos JP, Kemppainen EA, Mayer JM, et al. Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. Lancet. 2000;355:1955-1960.
16. Thiery J, Teupser D, Walli AK, et al. Study of causes underlying the low atherosclerotic response to dietary hypercholesterolemia in a selected strain of rabbits. Atherosclerosis. 1996;121:63-73.
17. Takaori K, Inoue K, Kogire M, et al. Effects of endothelin on microcirculation of the pancreas. Life Sci. 1992;51:615-622.
18. Hof RP, Hof A, Takiguchi Y. Massive regional differences in the vascular effects of endothelin. J Hypertens Suppl. 1989;7:S274-S275.
19. Ruetten H, Thiemermann C. Endothelin-1 stimulates the biosynthesis of tumour necrosis factor in macrophages: ET-receptors, signal transduction and inhibition by dexamethasone. J Physiol Pharmacol. 1997;48:675-688.
20. McMillen MA, Sumpio BE. Endothelins: polyfunctional cytokines. J Am Coll Surg. 1995;180:621-637.
21. Peralta C, Bulbena O, Bargallo R, et al. Strategies to modulate the deleterious effects of endothelin in hepatic ischemia-reperfusion. Transplantation. 2000;70:1761-1770.
22. Tanaka W, Yamanaka N, Onishi M, et al. Optimal route of administration of mixed endothelin receptor antagonist (TAK-044) in liver transplantation. J Gastroenterol. 2000;35:120-126.
23. Fukunaga K, Takada Y, Taniguchi H, et al. Endothelin antagonist treatment for successful liver transplantation from non-heart-beating donors. Transplantation. 1999;67:328-332.
24. Wilhelm SM, Stowe NT, Robinson AV, Schulak JA. The use of the endothelin receptor antagonist, tezosentan, before or after renal ischemia protects renal function. Transplantation. 2001;71:211-216.
25. Wolfard A, Vangel R, Szalay L, et al. Endothelin-A receptor antagonism improves small bowel graft perfusion and structure after ischemia and reperfusion. Transplantation. 1999;68:1231-1238.
26. Post S, Rentsch M, Gonzalez AP, et al. Importance of the first minutes of reperfusion in hepatic preservation injury. Transplant Proc. 1995;27:727-728.
27. Benz S, Bergt S, Obermaier R, et al. Impairment of microcirculation in the early reperfusion period predicts the degree of graft pancreatitis in clinical pancreas transplantation. Transplantation. 2001;71:759-763.
28. Benz S, Wiessner R, Obermaier R, et al. Microcirculatory events in ischemia/reperfusion of the pancreas defined by continuous tissue oximetry. Transpl Int. 2002;15:173-179.
29. Belzer FO, D'Alessandro AM, Hoffmann RM, et al. The use of UW solution in clinical transplantation. A 4-year experience. Ann Surg. 1992;215:579-583; discussion 584-585.
30. Kallen R, Montgomery A, Borgstrom A. Frotease activation following reperfusion of porcine pancreatic allografts. J Surg Res. 1992;53:495-501.
31. Vollmar B, Janata J, Yamauchi J, et al. Exocrine, but not endocrine, tissue is susceptible to microvascular ischemia/reperfusion injury following pancreas transplantation in the rat. Transpl Int. 1999;12:50-55.
32. Kubes P. The role of shear forces in ischemia/reperfusion-induced neutrophil rolling and adhesion. J Leukoc Biol. 1997;62:458-464.
33. Menger MD, Steiner D, Messmer K. Microvascular ischemia-reperfusion injury in striated muscle: significance of "no reflow". Am J Physiol. 1992;263:H1892-H1900.
34. Schilling MK, Redaelli C, Reber PU, et al. Microcirculation in chronic alcoholic pancreatitis: a laser Doppler flow study. Pancreas. 1999;19:21-25.
35. Studley JG, Mathie RT, Blumgart LH. Regional pancreatic perfusion. An experimental study in the dog. Acta Chir Scand. 1986;152:373-378.
36. Benz S, Schnabel R, Weber H, et al. The nitric oxide donor sodium nitroprusside is protective in ischemia/reperfusion injury of the pancreas. Transplantation. 1998;66:994-999.
37. Vollmar B, Janata J, Yamauchi JI, Menger MD. Attenuation of microvascular reperfusion injury in rat pancreas transplantation by L-arginine. Transplantation. 1999;67:950-955.
38. Sonin NV, Garcia-Pagan JC, Nakanishi K, et al. Patterns of vasoregulatory gene expression in the liver response to ischemia/reperfusion and endotoxemia. Shock. 1999;11:175-179.
39. Bourgeois C, Robert B, Rebourcet R, et al. Endothelin-1 and ETA receptor expression in vascular smooth muscle cells from human placenta: a new ETA receptor messenger ribonucleic acid is generated by alternative splicing of exon 3. J Clin Endocrinol Metab. 1997;82:3116-3123.
40. Browatzki M, Schmidt J, Kubler W, et al. Endothelin-1 induces interleukin-6 release via activation of the transcription factor NF-kappaB in human vascular smooth muscle cells. Basic Res Cardiol. 2000;95:98-105.
41. Le JM, Vilcek J. Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab Invest. 1989;61:588-602.